Displaying drugs 76 - 100 of 406 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Satralizumab | 143000.0 |  | A subcutaneously injected anti-IL-6 receptor monoclonal antibody for the treatment of neuromyelitis optica spectrum disorder (NMOSD). | Interleukin Inhibitors |
| Sarilumab | 150000.0 C6388H9918N1718O1998S44 |  | A monoclonal antibody used to treat moderate to severe rheumatoid arthritis who have responded poorly or are intolerant of other DMARDs. | Interleukin Inhibitors |
| Sargramostim | 14434.5 C639H1006N168O196S8 |  | A modified form of recombinant human granulocyte-macrophage colony stimulating factor used to increase immune cell production after myelosuppressive therapy or bone marrow transplant. | Colony-Stimulating Factors |
| Salmon calcitonin | 3431.853 C145H240N44O48S2 |  | A synthetic peptide form of calcitonin used to inhibit bone resorption in the treatment of hypercalcemia, osteoporosis, and Paget's disease. | Bone Density Conservation Agents / Bone Density, drug effects / Calcitonin Preparations / Calcium-Regulating Hormones and Agents / Neuropeptides / Peptide Hormones / Thyroid Products |
| Sacrosidase | Not Available | | An enzyme replacement therapy used for the treatment of congenital sucrase-isomaltase deficiency (CSID). | Enzymes |
| Sacituzumab govitecan | Not Available | | Sacituzumab govitecan targets TROP-2-expressing cancer cells through a humanized antibody (RS7) before subsequently becoming internalized and releasing the topoisomerase I inhibitor SN-38 to induce DNA damage-mediated apoptosis. | Alkaloids / Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Antibody-drug Conjugates / Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / Blood Proteins / Cancer immunotherapy / Globulins / Immunoglobulins / Immunologic Factors / Immunoproteins / Immunotherapy / MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES / Noxae / Proteins / Serum Globulins / Topoisomerase Inhibitors / Toxic Actions / Trop-2-Directed Monoclonal Antibodies / UGT1A1 Substrates |
| Rurioctocog alfa pegol | 269812.0 C12257H17863N3220O3552S83 | | A pegylated recombinant human coagulation factor VIII used to treat and prevent bleeding episodes in patients 12 years and above with hemophilia A. | Coagulants / Recombinant Proteins |
| Rozanolixizumab | 148000.0 | | A humanized monoclonal antibody targeting the human neonatal Fc receptor (FcRn) used to treat generalized myasthenia gravis. | Immunosuppressive Agents |
| Ropeginterferon alfa-2b | 60000.0 C16H29N3O6(C2H4O)n(C2H4O)n |  | A mono-pegylated type I interferon used to treat polycythemia vera. | Interferons |
| Romosozumab | 145805.0 | | A monoclonal antibody used to treat osteoporosis in postmenopausal women at high risk of fracture, patients who are intolerant of other treatments, or patients who have failed other treatments. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Blood Proteins / Bone Anabolic Agents / Drugs Affecting Bone Structure and Mineralization / Drugs for Treatment of Bone Diseases / Globulins / Immunoglobulins / Immunoproteins / Musculo-Skeletal System / Proteins / Sclerostin Inhibitors / Serum Globulins |
| Romiplostim | 59000.0 C2634H4086N722O790S18 | | A fusion protein thrombopoietin (TPO) peptide analog that increases platelet counts by binding to and activating the human TPO receptor. Used to treat thrombocytopenia associated with chronic immune thrombocytopenia (ITP). | Receptors, Thrombopoietin, agonists / Thrombopoietin Receptor Agonist |
| Rituximab | 143859.7 C6416H9874N1688O1987S44 |  | A monoclonal anti-CD20 antibody used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, pemphigus vulgaris, and rheumatoid arthritis. | Antibodies, Monoclonal / CD20 (Clusters of Differentiation 20) inhibitors |
| Risankizumab | 149000.0 C6476H9992N1720O2016S44 | | An interleukin-23 antagonist used to treat plaque psoriasis, psoriatic arthritis, and Crohn's disease in adults. | Interleukin Inhibitors |
| Rilonacept | 251000.0 C9030H13932N2400O2670S74 | | An IL-1 inhibitor used to treat cryopyrin-associated periodic syndrome, a rare hereditary inflammatory disorder. | Interleukin Inhibitors |
| rhThrombin | Not Annotated | | Investigated for use/treatment in blood (blood forming organ disorders, unspecified) and hemorrhage. | Not Annotated |
| Retifanlimab | 148000.0 C6456H9934N1702O2032S46 | | A PD-1–blocking antibody indicated for the treatment of adult patients with metastatic or recurrent locally advanced Merkel cell carcinoma. | PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
| Reteplase | 39589.6 C1736H2671N499O522S22 |  | A purified form of human tissue plasminogen activator used in the emergency treatment of myocardial infarction, ischemic stroke, and pulmonary emboli. | Enzymes |
| Reslizumab | 147000.0 |  | An IL-5 antagonist used as an add-on maintenance treatment of patients with severe eosinophilic asthma in adults. | Anti-Asthmatic Agents / Interleukin-5 Antagonist |
| Relatlimab | 148000.0 C6472H9940O2026N1704S38 | | A monoclonal antibody targeted against LAG-3 which is used in combination with nivolumab for the treatment of unresectable or metastatic melanoma. | Immune Checkpoint Inhibitors |
| Regdanvimab | Not Available | | A monoclonal antibody targeted against the SARS-CoV-2 spike protein used to treat patients with COVID-19 who are at risk of progressing to severe COVID-19. | Antiviral monoclonal antibodies |
| Recombinant Cholera Toxin B Subunit | Not Annotated | | Recombinant Cholera Toxin B Subunit is an ingredient in the EMA-authorised product Dukoral. | Adjuvants, Immunologic / ADP Ribose Transferases / Bacterial Toxins / Cholera Toxin / Enterotoxins / Poisons |
| Raxibacumab | 142844.5367 C6320H9794N1702O1998S42 |  | A monoclonal antibody used in conjunction with an antibacterial regimen to treat patients with inhalational anthrax caused by Bacillus anthracis and for prophylaxis of inhalational anthrax when appropriate. | Antibacterial monoclonal antibodies / Specific Immunoglobulins |
| Ravulizumab | 148000.0 C6430H9888N1696O2028S48 | | A monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis. | Selective Immunosuppressants |
| Rasburicase | 34109.5 C1521H2381N417O461S7 |  | A recombinant form of urate-oxidase enzyme used to treat hyperuricemia following chemotherapy for leukemias and non-Hodgkin's lymphoma. | Detoxifying Agents for Antineoplastic Treatment |
| Ranibizumab | 48349.6111 C2158H3282N562O681S12 |  | A recombinant humanized monoclonal antibody and VEGF-A antagonist used for the management of macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema. | Antineovascularisation Agents |
Displaying drugs 76 - 100 of 406 in total